• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "To Treat, or Not to Treat, That is the Question: Biomarker-guided Adjuvant Chemotherapy for Stage II and III Gastric Cancer".

作者信息

Choi Yoon Young, Cheong Jae-Ho

机构信息

Department of Surgery, Yonsei University Health System, Seoul, Korea Yonsei Biomedical Research Institute, Seoul, Korea Department of Surgery, Yonsei University Health System, Seoul, Korea Yonsei Biomedical Research Institute, Seoul, Korea Brain Korea 21 PLUS Project for Medical Science, Seoul, Korea Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine, Seoul, Korea Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Ann Surg. 2019 Aug;270(2):e40-e41. doi: 10.1097/SLA.0000000000003102.

DOI:10.1097/SLA.0000000000003102
PMID:30480562
Abstract
摘要

相似文献

1
Comment on "To Treat, or Not to Treat, That is the Question: Biomarker-guided Adjuvant Chemotherapy for Stage II and III Gastric Cancer".对《治疗还是不治疗，这是个问题：生物标志物指导的II期和III期胃癌辅助化疗》的评论
Ann Surg. 2019 Aug;270(2):e40-e41. doi: 10.1097/SLA.0000000000003102.
2
Comment on "Microsatellite Instability as a Predictive Biomarker for Adjuvant Chemotherapy in Gastric Cancer": Are we There Yet?对《微卫星不稳定性作为胃癌辅助化疗的预测生物标志物》的评论：我们到那儿了吗？
Ann Surg. 2019 Aug;270(2):e39-e40. doi: 10.1097/SLA.0000000000003100.
3
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.单患者分类分析、微卫星不稳定性和爱泼斯坦-巴尔病毒状态预测II/III期胃癌的临床结局：CLASSIC试验结果
Yonsei Med J. 2019 Feb;60(2):132-139. doi: 10.3349/ymj.2019.60.2.132.
4
Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences.回复：关于《指导的必要性：通过证据、临床判断和患者偏好的相互作用优化II/III期微卫星高度不稳定胃癌的辅助治疗》的评论
J Gastric Cancer. 2024 Oct;24(4):353-355. doi: 10.5230/jgc.2024.24.e40.
5
Carcinoma microsatellite instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for stage II rectal cancer.癌微卫星不稳定性状态作为II期直肠癌氟尿嘧啶辅助化疗获益的预测指标。
Asian Pac J Cancer Prev. 2015;16(4):1545-51. doi: 10.7314/apjcp.2015.16.4.1545.
6
Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.通过微卫星不稳定性预测5-氟尿嘧啶辅助化疗在胃癌中的疗效：一项荟萃分析
J Environ Pathol Toxicol Oncol. 2019;38(1):21-28. doi: 10.1615/JEnvironPatholToxicolOncol.2018026876.
7
The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.微卫星不稳定性对 II 期和 III 期胃癌化疗的获益减弱：一项大型队列研究的结果及亚组分析。
Int J Cancer. 2015 Aug 15;137(4):819-25. doi: 10.1002/ijc.29449. Epub 2015 Feb 26.
8
Chemotherapy for resectable microsatellite instability-high gastric cancer?可切除的微卫星高度不稳定型胃癌的化疗？
Lancet Oncol. 2020 Feb;21(2):204. doi: 10.1016/S1470-2045(20)30025-5.
9
Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection.散发性胃癌中的微卫星不稳定性：其预后作用及对 R0 切除术后基于 5-FU 的化疗的指导意义。
Int J Cancer. 2012 Jul 15;131(2):505-11. doi: 10.1002/ijc.26399. Epub 2011 Nov 19.
10
Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.IGF1R基因表达在接受根治性手术及S-1辅助化疗的II/III期胃癌患者中的临床意义
J Cancer Res Clin Oncol. 2016 Feb;142(2):415-22. doi: 10.1007/s00432-015-2039-6. Epub 2015 Sep 3.

引用本文的文献

1
Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research.基于中国人的研究：D2 胃切除术后 II 期胃癌患者的生存分析。
BMC Gastroenterol. 2021 Oct 7;21(1):363. doi: 10.1186/s12876-021-01937-9.
2
A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer.一项关于可切除胃癌复发后微卫星不稳定性或错配修复状态预后意义的多队列研究
Cancer Res Treat. 2020 Oct;52(4):1153-1161. doi: 10.4143/crt.2020.173. Epub 2020 May 4.
3
Clinical Implications of Microsatellite Instability in Early Gastric Cancer.
早期胃癌中微卫星不稳定性的临床意义
J Gastric Cancer. 2019 Dec;19(4):427-437. doi: 10.5230/jgc.2019.19.e38. Epub 2019 Nov 8.
4
Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon.一万例连续胃癌胃切除术：一位外科大师的观点
Yonsei Med J. 2019 Mar;60(3):235-242. doi: 10.3349/ymj.2019.60.3.235.
5
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.单患者分类分析、微卫星不稳定性和爱泼斯坦-巴尔病毒状态预测II/III期胃癌的临床结局：CLASSIC试验结果
Yonsei Med J. 2019 Feb;60(2):132-139. doi: 10.3349/ymj.2019.60.2.132.